Internal Medicine · Philadelphia, PA
NPI
1346229044
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
109 N 9th St
Philadelphia, PA, 19107
Phone (215) 923-2810
Medicare paid, 2024
$152K
2,176 services
Medicare patients, 2024
168
Average age 76
Drug cost, 2024
$1.8M
16,254 prescriptions
Company payments, 2025
$1,243
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Simon Yongquan Su was code 99214 (office e&m - established), 529 times for 146 patients. In total Simon Yongquan Su billed 2,176 services in 39 codes, and Medicare paid $152K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-04-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 529 | 146 | $96.87 | $51K |
| 99213 Office E&M - Established | Office | 220 | 96 | $68.96 | $15K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 177 | 18 | $49.07 | $8,685 |
| 99211 Office E&M - Established | Office | 170 | 109 | $17.20 | $2,924 |
| 99497 Care Management/Coordination | Office | 114 | 110 | $81.31 | $9,269 |
| 36415 Venipuncture Blood Collection | Office | 107 | 68 | $8.65 | $926 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 95 | 95 | $132.80 | $13K |
| G0008 Administration of influenza virus vaccine | Office | 90 | 87 | $33.29 | $2,996 |
| 90662 Vaccine Product | Office | 86 | 84 | $81.02 | $6,967 |
| 90480 Vaccine Administration | Office | 73 | 64 | $44.39 | $3,240 |
| 91322 Vaccine Product | Office | 73 | 64 | $149.55 | $11K |
| G0454 Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist | Office | 44 | 34 | $6.38 | $281 |
| 99212 Office E&M - Established | Office | 44 | 38 | $42.05 | $1,850 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 44 | 44 | $19.36 | $852 |
| G0136 Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes | Office | 35 | 35 | $10.85 | $380 |
By year: 2022 $181K for 2,605 services; 2023 $252K for 3,380 services; 2024 $152K for 2,176 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 107 | 68 | $8.65 | $926 |
Medicare prescription drug claims, 2024
In 2024, the drug Simon Yongquan Su prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,567 prescriptions and refills. In total Simon Yongquan Su wrote 16,254 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,567 | 2,952 | 289 | $13K |
| Amlodipine Besylate Generic | 1,141 | 2,134 | 202 | $4,369 |
| Metformin Hcl Generic | 880 | 1,699 | 154 | $4,618 |
| Hydrochlorothiazide Generic | 586 | 1,075 | 103 | $1,013 |
| Losartan Potassium Generic | 577 | 1,070 | 102 | $4,470 |
| Simvastatin Generic | 496 | 1,035 | 93 | $2,871 |
| Omeprazole Generic | 483 | 549 | 127 | $2,488 |
| Lisinopril Generic | 466 | 836 | 78 | $1,589 |
| Alendronate Sodium Generic | 387 | 622 | 65 | $2,897 |
| Tamsulosin Hcl Generic | 385 | 660 | 66 | $4,641 |
| Shingrix Varicella-Zoster Ge/As01b/Pf | 325 | 325 | 218 | $70K |
| Allopurinol Generic | 317 | 587 | 53 | $2,595 |
| Metoprolol Succinate Generic | 256 | 424 | 44 | $2,375 |
| Januvia Sitagliptin Phosphate | 224 | 315 | 36 | $170K |
| Atenolol Generic | 221 | 387 | 38 | $739 |
Brand drugs: 2,696 claims; generic drugs: 13,249 claims; opioid claims: 35.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Simon Yongquan Su $1,243 ($1,243 in general payments such as food, travel and fees) from 10 companies. The largest payer was Aimmune Therapeutics, Inc. with $303.
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 22 | $303 |
| Abbvie Inc. ABBV | 12 | $202 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $178 |
| Novo Nordisk Inc NVO | 9 | $167 |
| Amgen Inc. AMGN | 8 | $142 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $89.67 |
| Gilead Sciences, Inc. GILD | 4 | $83.49 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $37.38 |
| Lilly USA, LLC LLY | 1 | $22.26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.